India, Jan. 14 -- In furtherance to letter dated May 29, 2019 whereby it had informed the stock exchanges that the Board of Directors of the Company at its meeting held on May 29, 2019 had approved issuance of bonds, whether denominated in Indian Rupee or foreign currency, for an aggregate amount not exceeding USD 200 million in the international market as per applicable law, Glenmark Pharmaceuticals has informed that the Company is contemplating issuance of USD denominated notes for an aggregate amount not exceeding $ 200 million (Notes) subject to market conditions, and the Company's officials will be participating in roadshow presentations from January 14, 2020 to January 19, 2020 covering Asia, Europe and Middle East.

The above inform...